BML Capital Management »

Pliant Therapeutics shares owned by BML Capital Management

Quarter-by-quarter ownership of Pliant Therapeutics (PLRX) shares owned by BML Capital Management from 13F filings

Historical chart of BML Capital Management investment in Pliant Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Pliant Therapeutics held by BML Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pliant Therapeutics by BML Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.9M 1.5M 1.22

More positions owned by BML Capital Management

Aclaris Therapeutics (ACRS)
Atea Pharmaceuticals (AVIR)
Oramed Pharmaceuticals Com New (ORMP)
Instil Bio Com New (TIL)
Pmv Pharmaceuticals (PMVP)
CarMax (KMX)
Kezar Life Sciences Com New (KZR)
Target Corporation (TGT)
Carvana Cl A Put Option (CVNA)
Outset Med Com New (OM)
Pliant Therapeutics (PLRX)
Imagenebio (IMA)
Connect Biopharma Hldgs SHS (CNTB)
Wal-Mart Stores Put Option (WMT)
Tesla Motors Put Option (TSLA)

View all positions for BML Capital Management

Top funds holding Pliant Therapeutics

Tang Capital Management
Blue Owl Capital Holdings
Vanguard Group
Citadel Advisors
Acadian Asset Management
Jpmorgan Chase & Co
Woodline Partners
Monaco Asset Management SAM
Redmile Group
Prosight Management
BML Capital Management
Marshall Wace
BlackRock
Two Sigma Advisers
UBS Group

View all funds holding Pliant Therapeutics